National Center for Injury Prevention and Control Initial Review Group, 12690-12691 [05-5019]
Download as PDF
<![CDATA[
12690
Federal Register / Vol. 70, No. 49 / Tuesday, March 15, 2005 / Notices
medical records are available and in
proper order; (B) provide for the
identification of refugees who have been
determined to have medical conditions
affecting public health and requiring
treatment; (C) assure that State or local
health officials at the resettlement
destination of each refugee within the
United States are promptly notified of
the refugee’s arrival and provided with
all applicable medical records; and (D)
provide for such monitoring of refugees
identified under subparagraph (B) as
will insure that they receive appropriate
and timely treatment. The Secretary,
DHHS, shall develop and implement
methods for monitoring and assessing
the quality of medical screening and
related health services provided to
refugees awaiting resettlement in the
United States.
On July 3, 2003, the Secretary, DHHS,
delegated to the Director, CDC, the
authority to re-delegate the authorities
vested in the Secretary, DHHS, under
section 412(b)(4) of the INA (8 U.S.C.
1522(b)(4)), as amended hereafter. The
Division of Global Migration and
Quarantine (DGMQ), CDC, is
responsible for monitoring the
performance and quality of the required
overseas medical examinations of
refugees and immigrants applying for
permanent residence in the United
States, and notifying state and local
public health officials of the arrival of
all refugees and immigrants who have
Class A and B health conditions, (as
defined in 42 CFR 34.2) to facilitate the
recommended follow-up evaluation in
the U.S. Currently, the Department of
State uses medical examination forms
DS 2053, 3024, 3025, and 3026, under
OMB control number 1405–0113, to
conduct the overseas medical evaluation
of refugees and immigrants. This type of
communication and data exchange with
local partners has been critical in
identifying medical conditions among
refugees that require overseas
interventions.
In 2004, several outbreaks of vaccinepreventable diseases among refugees in
overseas refugee camps were identified
and controlled because of rapid
notification by U.S. state and local
health departments of cases in resettled
refugees. Since March 2004, DGMQ has
been working with the U.S. Department
of State, Bureau of Population, Refugees,
Number of
respondents
Respondents
and Migration and the International
Organization for Migration (IOM) to
resettle approximately 15,000 Laotian
Hmong refugees accepted for U.S.
resettlement. Approximately 8,800
refugees have arrived into the United
States through early January 2005, and
resettled to 27 states. DGMQ and the
Division of Tuberculosis Elimination
(DTBE) at CDC have recently received
reports from one state of six active TB
cases among Hmong refugees. Two of
the three cultures confirmed TB cases
were multi-drug resistant. In addition,
IOM, the group performing overseas
medical examinations has reported that
since July, 2004 to present, 166 suspect
active TB cases have been identified
among U.S.-bound Hmong refugees.
Completing the worksheet and
furnishing the requested information is
essential. Accurate information will
allow important public health functions
and follow-up of significant health
events to be performed in preventing the
spread of a disease. Respondents
include state and local health
departments. There is no cost to the
respondents other than their time.
Annualized Burden Table:
Number of
responses per
respondent
Average burden
per response
(in hours)
Total burden
(in hrs.)
State and local health agencies ..............................................................
300
170
5/60
4,250
Total ..................................................................................................
300
..........................
..........................
4,250
Dated: March 7, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–4937 Filed 3–14–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting:
Name: National Center for Injury
Prevention and Control (NCIPC), Initial
Review Group (IRG).
Times and Dates: 6:30 p.m.–9:30 p.m.,
April 18, 2005. 8:30 a.m.–5 p.m., April 19,
2005. 8 a.m.–5 p.m., April 20, 2005.
VerDate jul<14>2003
15:31 Mar 14, 2005
Jkt 205001
Place: Hilton Atlanta Airport and Towers,
1031 Virginia Avenue, Atlanta, Georgia
30354.
Status: Closed: 6:30 p.m.–9:30 p.m., April
18, 2005. Closed: 8:30 a.m.–5 p.m., April 19,
2005. Closed: 8 a.m.–5 p.m., April 20, 2005.
Purpose: This group is charged with
providing advice and guidance to the
Secretary of Health and Human Services and
the Director, CDC, concerning the scientific
and technical merit of grant and cooperative
agreement applications received from
academic institutions and other public and
private profit and nonprofit organizations,
including State and local government
agencies, to conduct specific injury research
that focuses on prevention and control and
supports Injury Control Research Centers
(ICRCs).
Matters To Be Discussed: Agenda items
include an overview of the injury program,
discussion of the review process and
panelists’ responsibilities, and the review of
and vote on applications. Beginning at 7
p.m., April 18, through 3 p.m., April 20, the
Group will review individual research grant
and cooperative agreement applications
submitted in response to 10 Fiscal Year 2005
Request for Applications (RFAs) related to
the following individual research
announcements: #05012, Grants for Violence
related Injury Prevention: Suicidal Behavior,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Child Maltreatment, Youth Partner, Sexual
Violence; #05017, Grants for Prevent Intimate
Partner Violence; #05018, Cooperative
Agreement National Academic Center of
Excellence; #05020, Youth Violence through
Community-Level Change; #05021, Grants for
New Investigator; #05022, Grants to Prevent
Unintentional Injury; #05023, Grants for
Traumatic Injury Biomechanics Research;
#05024, Alcohol impaired driving; #05025,
Grants for Dissertation; #05029,
Dissemination Research on Fall Prevention.
In addition, the IRG will vote on the results
of a mid-course site visit conducted on a
current grantee in response to previous IRG
recommendations in accordance to RFA
#02043, pertaining to (ICRC). This portion of
the meeting will be closed to the public in
accordance with provisions set forth in
section 552b(c)(4) and (6), title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Executive Secretary, NCIPC IRG, CDC, 4770
Buford Highway, NE., M/S K02, Atlanta,
Georgia 30341–3724, telephone (770) 488–
1430.
E:\FR\FM\15MRN1.SGM
15MRN1
Federal Register / Vol. 70, No. 49 / Tuesday, March 15, 2005 / Notices
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 23, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–5019 Filed 3–14–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1269–N3]
Medicare Program; Emergency Medical
Treatment and Labor Act (EMTALA)
Technical Advisory Group (TAG)
Meeting and Announcement of
Members
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: In accordance with section
10(a) of the Federal Advisory Committee
Act (FACA) (5 U.S.C. Appendix 2), this
notice announces the first meeting of
the Emergency Medical Treatment and
Labor Act (EMTALA) Technical
Advisory Group (TAG). The purpose of
the EMTALA TAG is to review
regulations affecting hospital and
physician responsibilities under
EMTALA to individuals who come to a
hospital seeking examination or
treatment for medical conditions. This
notice also announces the newly
appointed members of the EMTALA
TAG. Interested parties are invited to
this meeting to present their comments
on the EMTALA regulations and
implementation.
DATES: Meeting Date: The meetings of
the EMTALA TAG announced in this
notice will be held on Wednesday,
March 30, 2005 and Thursday, March
31, 2005, from 9 a.m. until 5 p.m. each
day.
Registration Deadline for All
Participants: All presenters must
register by March 22, 2005.
Comment Deadline: Comments or
statements must be received by March
22, 2005.
ADDRESSES: Meeting Address: The
EMTALA TAG meeting will be held in
Room 305 A at the Hubert H. Humphrey
Building, 200 Independence Avenue,
SW., Washington, DC 20201.
VerDate jul<14>2003
15:31 Mar 14, 2005
Jkt 205001
Mailing and E-mail Addresses for
Inquiries or Comments: Inquiries or
comments regarding this meeting may
be sent to—Beverly J. Parker, Division of
Acute Care, Centers for Medicare &
Medicaid Services, Mail Stop C4–08–06,
7500 Security Boulevard, Baltimore, MD
21244–1850. Inquiries or comments may
also be e-mailed to
EMTALATAG@cms.hhs.gov.
Web Site Address for Additional
Information: For additional information
on the EMTALA TAG meeting agenda
topics, updated activities, and to obtain
Charter copies, please search our
Internet Web site at: https://
www.cms.hhs.gov/faca/emtalatag/
emtalatagpage.asp.
Mailing Address for Copies of the
EMTALA TAG Charter: Written requests
for copies of the EMTALA TAG Charter
should be sent to—Marianne M. Myers,
Division of Acute Care, Centers for
Medicare & Medicaid Services, Mailstop
C4–08–06, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
Submission of Comments or
Statements: Comments or statements
regarding EMTALA may be sent by
postal mail or e-mail to the inquiry/
comment addresses listed above. We
will accept written comments/
statements of three single-spaced, typed
pages or less that are received by March
22, 2005.
FOR FURTHER INFORMATION CONTACT:
Beverly J. Parker, (410) 786–5320.
Press inquiries are handled through
the CMS Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1866(a)(1)(I), 1866(a)(1)(N),
and 1867 of the Social Security Act (the
Act) impose specific obligations on
Medicare-participating hospitals that
offer emergency services. These
obligations concern individuals who
come to a hospital emergency
department and request or have a
request made on their behalf for
examination or treatment for a medical
condition. EMTALA applies to all these
individuals, regardless of whether or not
they are beneficiaries of any program
under the Act. Section 1867 of the Act
sets forth requirements for medical
screening examinations for emergency
medical conditions, as well as necessary
stabilizing treatment or appropriate
transfer. In addition, section 1867(h) of
the Act specifically prohibits a delay in
providing required screening or
stabilization services in order to inquire
about the individual’s payment method
or insurance status. Section 1867(d) of
the Act provides for the imposition of
civil monetary penalties on hospitals
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
12691
and physicians responsible for
negligently violating a requirement of
that section.
These provisions, taken together,
frequently referred to as the Emergency
Medical Treatment and Labor Act
(EMTALA), are also known as the
patient antidumping statute. EMTALA
was passed in 1986 as part of the
Consolidated Omnibus Budget
Reconciliation Act of 1985 (COBRA).
Congress enacted these antidumping
provisions in the Social Security Act
because of its concern with an
‘‘increasing number of reports’’ that
hospital emergency rooms were refusing
to accept or treat individuals with
emergency conditions if the individuals
did not have insurance.
Regulations implementing the
EMTALA legislation are set forth at 42
CFR 489.20(l), (m), (q) and (r)(1), (r)(2),
(r)(3), and 489.24. These regulations
incorporate changes made by a final rule
published in the September 9, 2003
Federal Register (68 FR 53222). We
published a final rule to clarify policies
relating to the responsibilities of
Medicare-participating hospitals and
physicians, under the provisions of
EMTALA, in treating individuals with
emergency medical conditions who
present to a hospital.
Section 945 of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (P.L.
108–173), requires that the Secretary
establish a Technical Advisory Group
(TAG) for advice concerning issues
related to EMTALA regulations and
implementation.
Section 945 of the MMA specifies that
the EMTALA TAG—
• Shall review the EMTALA
regulations;
• May provide advice and
recommendations to the Secretary
concerning these regulations and their
application to hospitals and physicians;
• Shall solicit comments and
recommendations from hospitals,
physicians, and the public regarding
implementation of such regulations; and
• May disseminate information
concerning the application of these
regulations to hospitals, physicians and
the public.
Section 945 of the MMA also specifies
the structure of the EMTALA TAG. It
states that the EMTALA TAG will be
composed of 19 members including the
Administrator of the Centers for
Medicare & Medicaid Services (CMS)
and the Inspector General of the
Department of Health and Human
Services (DHHS) in addition to the
number and type of individuals as
specified in each of the following
categories:
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 70, Number 49 (Tuesday, March 15, 2005)]
[Notices]
[Pages 12690-12691]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Injury Prevention and Control Initial Review
Group
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting:
Name: National Center for Injury Prevention and Control (NCIPC),
Initial Review Group (IRG).
Times and Dates: 6:30 p.m.-9:30 p.m., April 18, 2005. 8:30 a.m.-
5 p.m., April 19, 2005. 8 a.m.-5 p.m., April 20, 2005.
Place: Hilton Atlanta Airport and Towers, 1031 Virginia Avenue,
Atlanta, Georgia 30354.
Status: Closed: 6:30 p.m.-9:30 p.m., April 18, 2005. Closed:
8:30 a.m.-5 p.m., April 19, 2005. Closed: 8 a.m.-5 p.m., April 20,
2005.
Purpose: This group is charged with providing advice and
guidance to the Secretary of Health and Human Services and the
Director, CDC, concerning the scientific and technical merit of
grant and cooperative agreement applications received from academic
institutions and other public and private profit and nonprofit
organizations, including State and local government agencies, to
conduct specific injury research that focuses on prevention and
control and supports Injury Control Research Centers (ICRCs).
Matters To Be Discussed: Agenda items include an overview of the
injury program, discussion of the review process and panelists'
responsibilities, and the review of and vote on applications.
Beginning at 7 p.m., April 18, through 3 p.m., April 20, the Group
will review individual research grant and cooperative agreement
applications submitted in response to 10 Fiscal Year 2005 Request
for Applications (RFAs) related to the following individual research
announcements: 05012, Grants for Violence related Injury
Prevention: Suicidal Behavior, Child Maltreatment, Youth Partner,
Sexual Violence; 05017, Grants for Prevent Intimate Partner
Violence; 05018, Cooperative Agreement National Academic
Center of Excellence; 05020, Youth Violence through
Community-Level Change; 05021, Grants for New Investigator;
05022, Grants to Prevent Unintentional Injury;
05023, Grants for Traumatic Injury Biomechanics Research;
05024, Alcohol impaired driving; 05025, Grants for
Dissertation; 05029, Dissemination Research on Fall
Prevention. In addition, the IRG will vote on the results of a mid-
course site visit conducted on a current grantee in response to
previous IRG recommendations in accordance to RFA 02043,
pertaining to (ICRC). This portion of the meeting will be closed to
the public in accordance with provisions set forth in section
552b(c)(4) and (6), title 5 U.S.C., and the Determination of the
Director, Management Analysis and Services Office, CDC, pursuant to
Pub. L. 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gwendolyn H. Cattledge,
Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford
Highway, NE., M/S K02, Atlanta, Georgia 30341-3724, telephone (770)
488-1430.
[[Page 12691]]
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 23, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-5019 Filed 3-14-05; 8:45 am]
BILLING CODE 4163-18-P
